Difference between revisions of "Du WQ, et al. J. Cancer Res. Clin. (2009) cited as Ref 696 in DOI: 10.1038/s41392-020-0110-5 (Q9959)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 135, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 1277-1285, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer (English) | ||
| Property / title: EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 1277-1285 | ||
| Property / Page(s): 1277-1285 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:49, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Du WQ, et al. J. Cancer Res. Clin. (2009) cited as Ref 696 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Du WQ
0 references
2009
0 references
J. Cancer Res. Clin.
0 references
135
0 references
EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer (English)
0 references
1277-1285
0 references
